Stress in women: metabolic syndrome and polycystic ovary syndrome (Q36674824)

15 August 2017

1 reference

title

Stress in women: metabolic syndrome and polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

15 August 2017

1 reference

1 reference

1 reference

Evanthia Diamanti-Kandarakis

series ordinal

1

object named as

Evanthia Diamanti-Kandarakis

1 reference

15 August 2017

Frangiskos Economou

2

1 reference

PubMed ID

17148733

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Annals of the New York Academy of Sciences

15 August 2017

1 reference

15 August 2017

1083

1 reference

15 August 2017

54-62

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

15 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Polycystic ovary syndrome: syndrome XX?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Selective insulin resistance in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Polycystic ovary syndrome--long-term metabolic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Smaller LDL particle size in women with polycystic ovary syndrome compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Low grade chronic inflammation in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Role of stress in the pathogenesis of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Fetal programming of the neuroendocrine response to stress: links between low birth weight and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Anovulation after precocious pubarche: early markers and time course in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

The effect of polycystic ovary syndrome on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.006

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1367.006

1 reference

15 August 2017

1 reference

PubMed ID

17148733